Abstracts tagged "abatacept and biomarkers"

Abstract Number: 2067 • 2015 ACR/ARHP Annual Meeting
De-Convolution of Whole Blood Transcriptomic Data from a Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus
S Bandyopadhyay¹, SE Connolly¹, O Jabado¹, S Kelly¹, M Maldonado¹, R Westhovens², P Nash³, JT Merrill⁴ and R Townsend¹, ¹Bristol-Myers Squibb, Princeton, NJ, ²University Hospitals KU Leuven, Leuven, Belgium, ³University of Queensland, Brisbane, Australia, ⁴Oklahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: The Phase IIb IM101-042 trial was a randomized, double-blind, placebo-controlled trial of abatacept (ABA) in systemic lupus erythematosus patients (pts) with polyarthritis, discoid lesions…